Bausch Health Companies | VRX - Ebit

Stock Price
7.86
Daily Change
0.09 1.09%
Monthly
-23.07%
Yearly
-25.47%
Q1 Forecast
7.62

Bausch Health Companies reported $717M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Amgen USD 3.96B 464M Dec/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Bausch Health Companies USD 717M 112M Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 7.41B 391.2M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Novo Nordisk DKK 34.08B 4.71B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025
Zoetis USD 975M 40M Sep/2025